Acute kidney injury is being redefined as a collection of syndromes, each of which could be targeted by specific biomarkers.

The following is a summary of “Association between perioperative platelet distribution width changes and postoperative acute ...

Researchers from Johns Hopkins Medicine and Yale University have collaborated on the development and application of a ...

Advancements and Projections in the Acute Kidney Injury Treatment Market: Insights, Trends, Opportunities, and Recent ...

Canadian clinical trial company Arch Biopartners has dosed the first patient in Canada in its Phase II clinical trial of ...

The following is a summary of “Factors and machine learning models for predicting successful discontinuation of continuous ...

For the study, investigators analyzed medical records of patients who were treated with anti-cancer medications including cytotoxic, targeted immunotherapies over a 1-year period.

SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, has begun ...

A recent study published in Kidney Research and Clinical Practice has shed light on the impact of sacubitril-valsartan ...

SeaStar Medical (ICU) has begun shipping QUELIMMUNE to a third hospital customer. QUELIMMUNE is the Company’s Selective Cytopheretic ...

Chronic kidney disease (CKD) affects millions worldwide, and as the demand for effective dialysis treatments grows, ...

Arch Biopartners doses first patient in Canada for phase II trial of LSALT peptide to treat cardiac surgery associated acute kidney injury: Toronto Wednesday, November 13, 2024, 1 ...